Literature DB >> 20519629

microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.

Aldo M Roccaro1, Antonio Sacco, Xiaoying Jia, Abdel Kareem Azab, Patricia Maiso, Hai T Ngo, Feda Azab, Judith Runnels, Phong Quang, Irene M Ghobrial.   

Abstract

Waldenström macroglobulinemia (WM) cells present with increased expression of microRNA-206 (miRNA-206) and reduced expression of miRNA-9*. Predicted miRNA-206- and -9*-targeted genes include histone deacetylases (HDACs) and histone acetyl transferases (HATs), indicating that these miRNAs may play a role in regulating histone acetylation. We were able to demonstrate that primary WM cells are characterized by unbalanced expression of HDACs and HATs, responsible for decreased acetylated histone-H3 and -H4, and increased HDAC activity. We next examined whether miRNA-206 and -9* modulate the aberrant expression of HDAC and HATs in WM cells leading to increased transcriptional activity. We found that restoring miRNA-9* levels induced toxicity in WM cells, supported by down-modulation of HDAC4 and HDAC5 and up-regulation of acetyl-histone-H3 and -H4. These, together with inhibited HDAC activity, led to induction of apoptosis and autophagy in WM cells. To further confirm that miRNA-9*-dependent modulation of histone acetylation is responsible for induction of WM cytotoxicity, a novel class of HDAC inhibitor (LBH589) was used; we confirmed that inhibition of HDAC activity leads to toxicity in this disease. These findings confirm that histone-modifying genes and HDAC activity are deregulated in WM cells, partially driven by the aberrant expression of miRNA-206 and -9* in the tumor clone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519629      PMCID: PMC2938840          DOI: 10.1182/blood-2010-01-265686

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development.

Authors:  Fenghuang Zhan; Erming Tian; Klaus Bumm; Ruston Smith; Bart Barlogie; John Shaughnessy
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

3.  MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.

Authors:  Aldo M Roccaro; Antonio Sacco; Brian Thompson; Xavier Leleu; Abdel Kareem Azab; Feda Azab; Judith Runnels; Xiaoying Jia; Hai T Ngo; Molly R Melhem; Charles P Lin; Domenico Ribatti; Barrett J Rollins; Thomas E Witzig; Kenneth C Anderson; Irene M Ghobrial
Journal:  Blood       Date:  2009-04-28       Impact factor: 22.113

4.  Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells.

Authors:  Sylvie Côté; Angelika Rosenauer; Andrea Bianchini; Karen Seiter; Jonathan Vandewiele; Clara Nervi; Wilson H Miller
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

5.  microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.

Authors:  Aldo M Roccaro; Antonio Sacco; Changzhong Chen; Judith Runnels; Xavier Leleu; Feda Azab; Abdel Kareem Azab; Xiaoying Jia; Hai T Ngo; Molly R Melhem; Nicholas Burwick; Lyuba Varticovski; Carl D Novina; Barrett J Rollins; Kenneth C Anderson; Irene M Ghobrial
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

6.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

Authors:  Ramiro Garzon; Shujun Liu; Muller Fabbri; Zhongfa Liu; Catherine E A Heaphy; Elisa Callegari; Sebastian Schwind; Jiuxia Pang; Jianhua Yu; Natarajan Muthusamy; Violaine Havelange; Stefano Volinia; William Blum; Laura J Rush; Danilo Perrotti; Michael Andreeff; Clara D Bloomfield; John C Byrd; Kenneth Chan; Lai-Chu Wu; Carlo M Croce; Guido Marcucci
Journal:  Blood       Date:  2009-02-11       Impact factor: 22.113

7.  Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.

Authors:  Roelandt F J Schop; W Michael Kuehl; Scott A Van Wier; Gregory J Ahmann; Tammy Price-Troska; Richard J Bailey; Syed M Jalal; Ying Qi; Robert A Kyle; Philip R Greipp; Rafael Fonseca
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

8.  HDAC4 promotes growth of colon cancer cells via repression of p21.

Authors:  Andrew J Wilson; Do-Sun Byun; Shannon Nasser; Lucas B Murray; Kanyalakshmi Ayyanar; Diego Arango; Maria Figueroa; Ari Melnick; Gary D Kao; Leonard H Augenlicht; John M Mariadason
Journal:  Mol Biol Cell       Date:  2008-07-16       Impact factor: 4.138

9.  miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.

Authors:  E J Noonan; R F Place; D Pookot; S Basak; J M Whitson; H Hirata; C Giardina; R Dahiya
Journal:  Oncogene       Date:  2009-03-02       Impact factor: 9.867

10.  Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.

Authors:  Sooryanarayana Varambally; Qi Cao; Ram-Shankar Mani; Sunita Shankar; Xiaosong Wang; Bushra Ateeq; Bharathi Laxman; Xuhong Cao; Xiaojun Jing; Kalpana Ramnarayanan; J Chad Brenner; Jindan Yu; Jung H Kim; Bo Han; Patrick Tan; Chandan Kumar-Sinha; Robert J Lonigro; Nallasivam Palanisamy; Christopher A Maher; Arul M Chinnaiyan
Journal:  Science       Date:  2008-11-13       Impact factor: 47.728

View more
  54 in total

Review 1.  MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis.

Authors:  Jianzhen Xu; Yanfei Wang; Xiaorong Tan; Hongjuan Jing
Journal:  Autophagy       Date:  2012-03-23       Impact factor: 16.016

Review 2.  Causes and consequences of microRNA dysregulation.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

Review 3.  Molecular pathogenesis of Waldenstrom's macroglobulinemia.

Authors:  Esteban Braggio; Casey Philipsborn; Anne Novak; Lucy Hodge; Stephen Ansell; Rafael Fonseca
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

Review 4.  Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.

Authors:  Dahong Yao; Yingnan Jiang; Suyu Gao; Lei Shang; Yuqian Zhao; Jian Huang; Jinhui Wang; Shilin Yang; Lixia Chen
Journal:  Cell Prolif       Date:  2016-07-20       Impact factor: 6.831

5.  Regulation of miRNAs in human skeletal muscle following acute endurance exercise and short-term endurance training.

Authors:  Aaron P Russell; Severine Lamon; Hanneke Boon; Shogo Wada; Isabelle Güller; Erin L Brown; Alexander V Chibalin; Juleen R Zierath; Rod J Snow; Nigel Stepto; Glenn D Wadley; Takayuki Akimoto
Journal:  J Physiol       Date:  2013-06-24       Impact factor: 5.182

Review 6.  MicroRNA-mediated autophagic signaling networks and cancer chemoresistance.

Authors:  Banzhou Pan; Jun Yi; Haizhu Song
Journal:  Cancer Biother Radiopharm       Date:  2013-07-10       Impact factor: 3.099

Review 7.  The emerging role of acetylation in the regulation of autophagy.

Authors:  Agnes Bánréti; Miklós Sass; Yacine Graba
Journal:  Autophagy       Date:  2013-03-06       Impact factor: 16.016

8.  The bone marrow microenvironment in waldenstrom macroglobulinemia.

Authors:  Irene M Ghobrial; Patricia Maiso; Abdelkareem Azab; Yang Liu; Yong Zhang; Ghayas Issa; Feda Azab; Antonio Sacco; Phong Quang; Hai Ngo; Aldo Roccaro
Journal:  Ther Adv Hematol       Date:  2011-08

Review 9.  Epigenetic effects of paternal diet on offspring: emphasis on obesity.

Authors:  Yuriy Slyvka; Yizhu Zhang; Felicia V Nowak
Journal:  Endocrine       Date:  2014-07-06       Impact factor: 3.633

Review 10.  Novel treatment options for Waldenström macroglobulinemia.

Authors:  Houry Leblebjian; Amit Agarwal; Irene Ghobrial
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.